Offer - Urjas Oil for just ₹ 1 X
Glylup M is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Glylup M have also been mentioned below.
The correct dosage of Glylup M depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Glylup M include Stomach Upset, Difficulty urinating. While these are the most often observed Glylup M side effects, there are can be others also. These have been listed below. Normally, these side effects of Glylup M are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Glylup M's effect during pregnancy is Mild and Moderate while nursing. Further, the section on Glylup M related warnings talks about Glylup M's effects on the liver, heart and kidney.
Glylup M is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Heart Disease, Kidney Disease are examples of such conditions. Other conditions have been mentioned below in the Glylup M contraindications section.
Drug interactions for Glylup M have been reported in the medical literature. See below for a complete list.
You should also be aware that Glylup M is safe while driving, and is addiction.
Glylup M is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glylup M safe for pregnant women?
Pregnant women can consume [medicine]. Though Glylup M has mild side effects when taken during pregnany
Is the use of Glylup M safe during breastfeeding?
Glylup M may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Glylup M, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Glylup M.
What is the effect of Glylup M on the Kidneys?
There are no side effects of Glylup M on the kidneys.
What is the effect of Glylup M on the Liver?
Glylup M is completely safe for the liver.
What is the effect of Glylup M on the Heart?
Glylup M is completely safe for the heart.
Glylup M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glylup M unless your doctor advises you to do so -
Is this Glylup M habit forming or addictive?
No, there is no any evidence that Glylup M is addictive.
Interaction between Food and Glylup M
Information is not available on the interaction of any foods with Glylup M, due to a lack of research on this.
Interaction between Alcohol and Glylup M
Consult your doctor before consuming alcohol while taking Glylup M as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucotrol - glipizide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826